Drug Shortage Report for PLAVIX
| Report ID | 169210 |
| Drug Identification Number | 02238682 |
| Brand name | PLAVIX |
| Common or Proper name | PLAVIX |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLOPIDOGREL |
| Strength(s) | 75MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Blister of 28 Tablets |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-09-12 |
| Estimated end date | 2023-01-31 |
| Actual end date | 2023-01-17 |
| Shortage status | Resolved |
| Updated date | 2023-01-18 |
| Company comments | Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: [email protected] Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2023-01-18 | English | Compare |
| v11 | 2023-01-17 | French | Compare |
| v10 | 2023-01-17 | English | Compare |
| v9 | 2022-12-14 | French | Compare |
| v8 | 2022-12-14 | English | Compare |
| v7 | 2022-11-30 | French | Compare |
| v6 | 2022-11-30 | English | Compare |
| v5 | 2022-10-12 | French | Compare |
| v4 | 2022-10-12 | English | Compare |
| v3 | 2022-09-13 | French | Compare |
| v2 | 2022-09-13 | English | Compare |
| v1 | 2022-09-13 | English | Compare |
Showing 1 to 12 of 12